[Clinical significance of a new spasmolytic kellidrin].
D000787:Angina Pectoris / Q000628:therapy*; D001921:Brain / Q000098:blood supply*; D002317:Cardiovascular Agents; D007666:Khellin / Q000627:therapeutic use*; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010276:Parasympatholytics; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central; D010276:Parasympatholytics; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D007666:Khellin
ANGINA PECTORIS/therapy; BRAIN/blood supply; KHELLIN/therapeutic use; MUSCLE RELAXANTS/therapeutic use; VASOMOTOR DRUGS/therapeutic use
Uber die Wirksamkeit des neuen Spasmolytikums "Kellidrin" in der Klinik.